These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12440407)

  • 41. Cost-effectiveness of universal pneumococcal vaccination for infants in Italy.
    Lucioni C; Mazzi S
    Vaccine; 2006 Mar; 24(11):1735. PubMed ID: 16356601
    [No Abstract]   [Full Text] [Related]  

  • 42. Improving Pneumococcal Immunization Rates Among Hospitalized Adults.
    Schurlknight M
    Nurs Econ; 2015; 33(3):182-5. PubMed ID: 26259344
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cost-benefit and cost-effectiveness of the incorporation of the pneumococcal 7-valent conjugated vaccine in the routine vaccination schedule of Catalonia (Spain).
    Navas E; Salleras L; Gisbert R; Domínguez A; Timoner E; Ibáñez D; Prat A
    Vaccine; 2005 Mar; 23(17-18):2342-8. PubMed ID: 15755625
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pneumococcal conjugate vaccine: economic issues of the introduction of a new childhood vaccine.
    Ray GT
    Expert Rev Vaccines; 2002 Jun; 1(1):65-74. PubMed ID: 12908513
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pneumococcal vaccination for healthy elderly: a comment.
    van den Bosch WJ
    Neth J Med; 2004 Feb; 62(2):66-8. PubMed ID: 15127835
    [No Abstract]   [Full Text] [Related]  

  • 46. Influenza and pneumococcal disease in the community.
    Riley C; Riley S
    Nurs Stand; 2003 Oct 8-14; 18(4):45-51; quiz 52, 55. PubMed ID: 14601214
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Splenectomy and pneumococcal vaccination].
    Postma MJ; Heijnen MA; de Vries R; Beutels P; Jager JC
    Ned Tijdschr Geneeskd; 2003 Jun; 147(23):1141-2; author reply 1142. PubMed ID: 12822527
    [No Abstract]   [Full Text] [Related]  

  • 48. Prevalence of influenza vaccination and pneumococcal vaccination in elderly and high-risk patients seen in a university general medicine clinic.
    Lai H; Aronow WS; Gutwein AH
    Am J Ther; 2008; 15(6):528-30. PubMed ID: 19127136
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Health care utilization for pneumonia in young children after routine pneumococcal conjugate vaccine use in the United States.
    Zhou F; Kyaw MH; Shefer A; Winston CA; Nuorti JP
    Arch Pediatr Adolesc Med; 2007 Dec; 161(12):1162-8. PubMed ID: 18056561
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pneumococcal preventive vaccination. Consensus report, 3].
    Ambrosch F; Francesconi M; Graf H; Huber W; Kollaritsch H; Kunze M; Maurer G; Popp W; Prior C; Sertl K; Slany J; Wiedermann G
    Wien Med Wochenschr; 1998; 148(8-9):203. PubMed ID: 9677677
    [No Abstract]   [Full Text] [Related]  

  • 51. A health plan intervention to improve pneumococcal vaccination in the elderly.
    Yanagihara DM; Taira DA; Davis J; Gronley KA; Marciel C; Lee E; Tice A
    Manag Care Interface; 2005 Sep; 18(9):25-30. PubMed ID: 16209136
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The number needed to vaccinate (NNV) and population extensions of the NNV: comparison of influenza and pneumococcal vaccine programmes for people aged 65 years and over.
    Kelly H; Attia J; Andrews R; Heller RF
    Vaccine; 2004 Jun; 22(17-18):2192-8. PubMed ID: 15149776
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhanced decision support for policy makers using a web interface to health-economic models--illustrated with a cost-effectiveness analysis of nation-wide infant vaccination with the 7-valent pneumococcal conjugate vaccine in the Netherlands.
    Hubben GA; Bos JM; Glynn DM; van der Ende A; van Alphen L; Postma MJ
    Vaccine; 2007 May; 25(18):3669-78. PubMed ID: 17360082
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pneumococcal vaccination of adults: polysaccharide or conjugate.
    Med Lett Drugs Ther; 2009 Jun; 51(1314):47-8. PubMed ID: 19528887
    [No Abstract]   [Full Text] [Related]  

  • 55. The cost-burden of paediatric pneumococcal disease in Sweden and the potential cost-effectiveness of prevention using 7-valent pneumococcal vaccine.
    Silfverdal SA; Berg S; Hemlin C; Jokinen I
    Vaccine; 2009 Mar; 27(10):1601-8. PubMed ID: 19146905
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increasing pneumococcal vaccination in managed care through telephone outreach.
    Winston CA; Mims AD; Leatherwood KA
    Am J Manag Care; 2007 Oct; 13(10):581-8. PubMed ID: 17927463
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe.
    Rose M; Zielen S
    Expert Rev Vaccines; 2009 Oct; 8(10):1351-64. PubMed ID: 19803758
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Summaries for patients. Cost-effectiveness of pneumococcal vaccine for people 50 through 64 years of age.
    Ann Intern Med; 2003 Jun; 138(12):I42. PubMed ID: 12809479
    [No Abstract]   [Full Text] [Related]  

  • 59. More benefits for the buck. Study reveals which healthcare services save more lives for fewer dollars.
    Dent Today; 2001 Sep; 20(9):35-6. PubMed ID: 11569200
    [No Abstract]   [Full Text] [Related]  

  • 60. Implementing an electronically based, nurse-driven pneumococcal vaccination protocol for inpatients.
    Kishel JJ; Maguire M; Pankratz L; Julian K
    Am J Health Syst Pharm; 2009 Jul; 66(14):1304-8. PubMed ID: 19574606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.